CBD stakeholders say they hope the appointment of a cannabis policy expert at the U.S. Food & Drug Administration (FDA) signals the agency may finally begin to establish a regulatory program. FDA has hired Norman Birenbaum, a former cannabis official in two states, to the position of senior public health advisor in its Center for Regulatory Programs...